한국어
English
日本語
中文(简体)Segluromet Tablet 7.5/1000 mg
Prescription medication · Combination
Korea MSD Co., Ltd.
Ertugliflozin L-Pyroglutamic Acid is a blood glucose-lowering ingredient used in the treatment of type 2 diabetes.
Ertugliflozin L-Pyroglutamic Acid belongs to the SGLT2 inhibitor class of diabetes medications. This ingredient is used to lower blood glucose levels by blocking glucose reabsorption in the kidneys. It primarily helps in the blood glucose control of patients with type 2 diabetes.
Ertugliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, increasing glucose elimination through urine. This reduces blood glucose concentration, lowering blood sugar levels. It acts independently of insulin secretion.
Approved uses differ by product. Check each product's information for its actual use.
Ertugliflozin is similar to other SGLT2 inhibitors but is formulated with L-Pyroglutamic Acid in an undifferentiated form to enhance drug absorption and stability. This optimizes the bioavailability and efficacy within the body. Additionally, some reports have indicated cardiovascular protective effects, providing a distinguishing feature.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
4 total
Prescription medication · Combination
Korea MSD Co., Ltd.
Prescription medication · Combination
Merck & Co., Inc.
Prescription medication · Combination
Korea MSD Co., Ltd.
Prescription medication · Combination
MSD Korea Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.